Campbells Regulatory Update – Q1 2023
06 Apr 2023This quarter’s Update provides an overview of the main legal developments in the Cayman Islands and the British Virgin Islands from 1 January to 31 March 2023.
This quarter’s Update provides an overview of the main legal developments in the Cayman Islands and the British Virgin Islands from 1 January to 31 March 2023.
Campbells is pleased to announce the appointments of Jane Hale, Guy Cowan and Kristy-Anne Leith* to Partner in our Hong Kong and Cayman Islands offices, effective 1 April 2023.
Our Hong Kong office has acted as the Cayman and BVI legal counsel to Runhua Living Service Group Holdings Limited in connection with its approximately HK$127.5 million initial public offering and listing.
Campbells advised Beauty Farm Medical and Health Industry Inc. on its approximately HK$783 million initial public offering on the Hong Kong Stock Exchange.
The latest Legal 500 Asia-Pacific Offshore rankings have placed our Hong Kong corporate and litigation practices ahead of the competition and one tier up from 2022.
This quarter’s Update provides an overview of the main legal developments in the Cayman Islands and the British Virgin Islands from 1 October to 31 December 2022.
Campbells is delighted to have advised Sipai Health Technology Co., Ltd., a company dedicated to connect and deliver clear values to patients, doctors, medical institutions, pharmaceutical companies and payers across China’s healthcare system through its robust technology platform.
Richard and his leading team of FinTech attorneys are trusted by many of the highest profile industry participants, and work seamlessly with Campbells’ market-leading insolvency and restructuring experts.
This update provides an overview of the main legal developments in the Cayman Islands and the British Virgin Islands over the last quarter.
Our Hong Kong office acted as Cayman Islands legal counsel to Rainmed Medical Limited in connection with its initial public offering and listing of its 23,348,000 shares (before exercise of over-allotment option) on the Main Board of the Hong Kong Stock Exchange.